Abiopharma

🔍 Corum Bethany Harding (Executive)

Company: CAPITAL CITY BANK GROUP INC (CCBG)

Report Date: 2026-08-28

Detailed Transactions and Holdings:

• Acquired 20 shares of Common Stock at $51.35 per share (Direct)
  Date: 2026-08-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: 401(k)Plan | shares_owned_after: 9,635.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | shares_owned_after: 16,332.00 | Footnotes: F2

Footnotes:

• F1: Includes 115 shares acquired through the Registrant's Dividend Reinvestment Plan (DRIP) since the reporting person's last Form 4 filing that were exempt from the reporting and short-swing profit provisions of Section16 of the Securities Exchange Act of 1934.
• F2: Includes 32 shares purchased through the Registrant's Associate Stock Purchase Plan (ASPP) that were exempt from the reporting and short-swing provisions of Section 16 of the Securities Exchange Act of 1934
• F3: Includes 31 shares acquired through the Registrant's Dividend Reinvestment Plan (DRIP) since the reporting person's last Form 4 filing that were exempt from the reporting and short-swing profit provisions of Section16 of the Securities Exchange Act of 1934.